AL
PCRX icon

Airain Ltd’s Pacira BioSciences PCRX Stock Holding History

Airain Ltd’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-15,946
Closed -$538K – 754
2016
Q2 		$538K Buy
+15,946
New +$784K 0.03% 429
2016
Q1 		– Sell
-3,655
Closed -$281K – 1007
2015
Q4 		$281K Sell
3,655
-2,040
-36% -$116K 0.02% 626
2015
Q3 		$234K Buy
+5,695
New +$349K 0.01% 658
2015
Q2 		– Sell
-3,232
Closed -$287K – 1033
2015
Q1 		$287K Buy
+3,232
New +$328K 0.02% 640

Other funds holding PCRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return